SBIR/STTR Research Award

Bitter Human Taste Bud Epithelial Cell Platforms for Bitter Taste Antagonist Discovery

Award identifier 85f61134e0f3fcc7b47a4a187f2ea7115fd0200073760bfc33c16229f0f79be9Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$286,536

Program and phase

STTR · Phase I

Award year

2018

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
DISCOVERYBIOMED, INC.
Proposal award date
2018-09-01
Contract end date
2019-08-31
UEI
LR7QH452JJ31
Solicitation number
PA18-906
Topic code
NIDCD

Research abstract

Principal Investigators for Small BusinessDiscoveryBioMedIncDBMand Monell Chemical Senses Center Project Summary Abstract Bitter taste in foods and medicines presents a barrier to overcoming global public health challengesfood insecuritypoor nutritional healthand poor compliance with medication useparticularly among children and the elderlySugar and saltthe mainstays to address these challengesfurther erode nutritional healthand current alternatives have adverse taste attributes of their ownWe propose to develop a reliablehuman tastecell screening platform to find bitter blockers of commercial interest to the foodflavorand pharmaceutical industrieswith the aim to improve the taste and acceptance of nutritious and sustainable foods and medicinesThis PhaseSTTR proposal has the following goalsato establish immortal human taste bud derived epithelial cell cultures and linesi ehTBEC platformsfrom donors with bitter sensitive genotypes andbto designoptimizeand implement hTBEC based bioassays of bitter taste receptor function and other key end points to produce readout data for high throughput screeningHTSThis proposed research is the initial step toward our ultimate goal of executing a full HTS based campaign to discover and validate bitter taste receptor antagonists from phytochemicalsphytochemical derivativesand botanical extracts and extract fractionsThis commercial academic collaboration between DiscoveryBioMedIncand Monell Chemical Senses Center brings together expertise inaculture of human taste cellsbthe creation of immortalized cell linescHTSandcgenetics and human sensory analysisThe hypothesis is that hTBEC platform based bioassays will provide a more relevant and robust way to identify new bitter antagonistsgiven the imperfect current methods of overexpressing known taste receptors in heterologous cellsThe discovery of bitter taste receptor antagonists that alone or blended will block bitter taste can improve healthy eating by reducing reliance on salt and sugar and can improve compliance by patients taking medicinesThusnew bitter blockers will improve human healthPHSRevre issuedPage Continuation Format PagePrincipal Investigators for Small BusinessDiscoveryBioMedIncDBMand Monell Chemical Senses Center Public Health Relevance Statement Bitter taste in foods and medicines stymies efforts to improve nutritional healthalleviate food insecurity and accounts in part for poor compliance by patientswho fail to take medication as prescribedSugar and saltthe mainstays to address these challengesfurther erode healthand current alternatives to these bitter masking compounds have adverse taste attributes of their ownWe propose to develop a reliablehuman taste cell screening platform to find acceptable bitter blockers of commercial interest to the foodflavorand pharmaceutical industriesto improve the taste and acceptance of nutritious and sustainable foods and medicinesPHSRevre issuedPage Continuation Format Page

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

19 SBIR/STTR records share this UEI (2008–2020). Reported award amounts total $11,512,428. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.